Mark Baldry

Insider Reports History

Entity
Individual
Location
C/O Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury, NJ
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Baldry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc Chief Commercial Officer Common Stock 48.5K $28.4K $0.58 Oct 7, 2024 Direct
X4 Pharmaceuticals, Inc Chief Commercial Officer Stock Appreciation Right 523K Feb 13, 2024 Direct

Insider Reports Filed by Mark Baldry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XFOR X4 Pharmaceuticals, Inc Oct 4, 2024 2 -$6.51K 4 Oct 8, 2024 Chief Commercial Officer
XFOR X4 Pharmaceuticals, Inc Feb 13, 2024 1 $0 4 Feb 16, 2024 Chief Commercial Officer
XFOR X4 Pharmaceuticals, Inc Nov 1, 2023 1 -$7.49K 4 Nov 3, 2023 Chief Commercial Officer
XFOR X4 Pharmaceuticals, Inc Oct 31, 2023 1 $0 4 Nov 2, 2023 Chief Commercial Officer
XFOR X4 Pharmaceuticals, Inc Nov 3, 2022 1 $644K 4 Nov 4, 2022 Chief Commercial Officer
XFOR X4 Pharmaceuticals, Inc Nov 3, 2022 0 $0 3 Nov 4, 2022 Chief Commercial Officer